Harper PS (2009) Myotonic dystrophy, 2nd edn. Oxford University Press, New York
Google Scholar
Yagi Y, Machida A, Toru S, Kobayashi T, Amano T, Hirokawa K, Kitagawa M (2012) Myotonic dystrophy and lipoma: a new association. Neurol Sci 33(6):1477–1478
Article
Google Scholar
Kalkman JS, Zwarts MJ, Schillings ML, van Engelen BG, Bleijenberg G (2008) Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue. Neurol Sci 29(Suppl 2):S238–S240
Article
Google Scholar
Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM (2008) Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 358(25):2688–2697
CAS
Article
Google Scholar
Petri H, Vissing J, Witting N, Bundgaard H, Kober L (2012) Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 160(2):82–88
Article
Google Scholar
Petri H, Witting N, Ersboll MK, Sajadieh A, Duno M, Helweg-Larsen S et al (2014) High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study. Int J Cardiol 174(1):31–36
Article
Google Scholar
Antonini G, Giubilei F, Mammarella A, Amicucci P, Fiorelli M, Gragnani F, Morino S, Ceschin V, Fragola PV, Gennarelli M (2000) Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats. Neurology 55(8):1207–1209
CAS
Article
Google Scholar
Melacini P, Villanova C, Menegazzo E, Novelli G, Danieli G, Rizzoli G, Fasoli G, Angelini C, Buja G, Miorelli M, Dallapiccola B, Volta SD (1995) Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol 25(1):239–245
CAS
Article
Google Scholar
Groh WJ, Lowe MR, Zipes DP (2002) Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol 13(5):444–448
Article
Google Scholar
Sugie K, Sugie M, Taoka T, Tonomura Y, Kumazawa A, Izumi T, Kichikawa K, Ueno S (2015) Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1. PLoS One 10(4):e0125051
Article
Google Scholar
Park D, Lee SH, Shin JH, Park JS (2018) Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats. Neuromuscul Disord 28(1):29–37
Article
Google Scholar
Park D, Park JS (2017) Quantitative assessment of trunk muscles involvement in patients with myotonic dystrophy type 1 using a whole body muscle magnetic resonance imaging. Eur Neurol 77(5–6):238–245
Article
Google Scholar
Hayashi K, Hamano T, Kawamura Y, Kimura H, Matsunaga A, Ikawa M, Yamamura O, Mutoh T, Higuchi I, Kuriyama M, Nakamoto Y (2016) Muscle MRI of the upper extremity in the myotonic dystrophy type 1. Eur Neurol 76(1–2):87–94
CAS
Article
Google Scholar
Park JS, Park D (2018) Five-year serial follow-up of muscle MRI in adult onset myotonic dystrophy type 1: a case report. Medicine 97(4):e9379
Article
Google Scholar
Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Kober L et al (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 16:59
Article
Google Scholar
Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68(4):799–808
CAS
Article
Google Scholar
Kwon MJ, Lee ST, Kim BJ, Sung DH, Kim JW, Ki CS (2010) Haplotype analysis of the myotonic dystrophy type 1 (DM1) locus in the Korean population. Ann Clin Lab Sci 40(2):156–162
CAS
PubMed
Google Scholar
Kleyweg RP, van der Meche FG, Meulstee J (1988) Treatment of Guillain-Barre syndrome with high-dose gammaglobulin. Neurology 38(10):1639–1641
CAS
Article
Google Scholar
Brooks D, Solway S, Gibbons WJ (2003) ATS statement on six-minute walk test. Am J Respir Crit Care Med 167(9):1287
Article
Google Scholar
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463
Article
Google Scholar
Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15(2):167–184
Article
Google Scholar
Bhakta D, Lowe MR, Groh WJ (2004) Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 147(2):224–227
Article
Google Scholar
Phillips MF, Harper PS (1997) Cardiac disease in myotonic dystrophy. Cardiovasc Res 33(1):13–22
CAS
Article
Google Scholar
Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879
Article
Google Scholar
Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F et al (2009) Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2(6):437–443
Article
Google Scholar
Weber KT, Brilla CG, Janicki JS (1993) Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 27(3):341–348
CAS
Article
Google Scholar
Kass DA, Bronzwaer JG, Paulus WJ (2004) What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94(12):1533–1542
CAS
Article
Google Scholar
Bu'Lock FA, Sood M, De Giovanni JV, Green SH (1999) Left ventricular diastolic function in congenital myotonic dystrophy. Arch Dis Child 80(3):267–270
CAS
Article
Google Scholar
Fragola PV, Calo L, Luzi M, Mammarella A, Antonini G (1997) Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy. Cardiology 88(6):498–502
CAS
Article
Google Scholar
Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, Fujimura H, Dirksen RT, Takahashi MP, Dulhunty AF, Sakoda S (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14(15):2189–2200
CAS
Article
Google Scholar
Tang ZZ, Yarotskyy V, Wei L, Sobczak K, Nakamori M, Eichinger K, Moxley RT, Dirksen RT, Thornton CA (2012) Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet 21(6):1312–1324
CAS
Article
Google Scholar
Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10(1):35–44
CAS
Article
Google Scholar